Found 0 matching trials
A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma PHASE2 This is a prospective, multicenter phase II trial designed to determine eff...
Show More Location
SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo
Learn More & Join Trial
Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL) PHASE1 The purpose of this study is to determine whether the combination of bendam...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma PHASE2 The purpose of this study is to evaluate the efficacy and safety of Zanubru...
Show More Learn More & Join Trial
Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab PHASE3 SUMMARY: This is a multi-center open label study to evaluate the safety and...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
FT576 in Subjects With Multiple Myeloma PHASE1 This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma PHASE1 A clinical study of safety and efficacy of treatment with Nivolumab and Ben...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma PHASE1 The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Show More Location
University of Arizona Cancer Center, Tucson
Learn More & Join Trial
Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy PHASE2 Patients with high tumor burden, low grade follicular lymphoma that has nev...
Show More Location
Winship Cancer Institute of Emory University
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma PHASE1 This is a multicenter, open label, single arm, phase I/II study. There will...
Show More Location
Universitätsmedizin Mainz
Learn More & Join Trial